Dec 9, 2021, 01:00 AM by User Not Found

Bio-IT World | A group of cell engineers and synthetic biologists at Harvard University and Massachusetts Institute of Technology (MIT) has developed a tech tool called “eToeholds” that could help improve the safety and efficacy of RNA and cell therapies, in addition to enabling new forms of detection.

Dec 8, 2021, 09:14 AM by User Not Found

Bio-IT World | The ultimate challenge of drug delivery—successfully getting a medicine into a cell—has several lines of pursuit when it comes to nucleic acid-based vaccines and the latest and greatest is an ancient cupping technique which, at least in rodents, is almost unfathomably good at driving immune responses. To say the Rutgers University research team was surprised by the finding would be an understatement.

Dec 6, 2021, 16:50 PM by

Dec 6, 2021, 16:50 PM by

Research will focus on CUH’s areas of disease expertise and specialism in cancer, cardiovascular disease and rare diseases New agreement covers 3 million patient records and brings the combined total of de-identified patient data directly accessible for medical research to 25.5 million patients

Dec 6, 2021, 16:50 PM by

Dec 3, 2021, 01:00 AM by User Not Found

Bio-IT World | At Oxford Nanopore’s virtual Community Meeting this week, CTO Clive Brown presented new chemistries, previewed the Apple iPad Pro-powered Mk1D with an integrated MinION, teased the diagnostic capacities of “outy” sequencing, unveiled a browser base caller, and more.

Dec 2, 2021, 01:00 AM by User Not Found

Bio-IT World | Platforms for machine-learning generative biology and cloud R&D, drug delivery chip for therapies at the tumor site, and AI-driven drug discovery and robotics.

Dec 1, 2021, 15:29 PM by

Vyasa announced that it has joined the NVIDIA Partner Network (NPN) as a Solution Advisor (SA) – Consultant partner. Inclusion in the program enhances the availability of Vyasa’s deep learning applications to NVIDIA’s customers and partners.

Dec 1, 2021, 15:17 PM by

CPhI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark

Dec 1, 2021, 15:17 PM by

Qlucore is delighted to announce a joint project with Heidelberg University Hospital to develop Qlucore Diagnostics - a medical device artificial intelligence (AI) powered software for improved clinical diagnostics of lung cancer.

Dec 1, 2021, 15:17 PM by

Curebase’s Enhanced Telemedicine Feature Expands Patient Access to Edesa Biotech Derm Study

Dec 1, 2021, 15:17 PM by

Caption Health is announcing that Joe DeVivo, President of Hospitals and Health Systems at Teladoc Health, is joining its board of directors. Mr. DeVivo will share his expertise in Med Tech and Health Tech, gleaned over decades in the industry, to help guide the company on its mission to democratize access to high-quality ultrasounds.

Dec 1, 2021, 15:17 PM by

RefleXion Medical, Inc., has been granted FDA Breakthrough Device Designation for its biology-guided radiotherapy (BgRT) for use in treating lung tumors. The breakthrough potential of BgRT lies in its ability to detect and then immediately treat multiple moving tumors. It is the first and only technology to use injected radiotracers to produce active signals, called emissions, from each tumor to guide treatment delivery.

Dec 1, 2021, 01:00 AM by User Not Found

Bio-IT World | TRENDS FROM THE TRENCHES—Tom Messina has worked in various roles for Johnson & Johnson dating back to 1999 and is currently an IT Director in J&J’s Pharmaceutical R&D division, Janssen. BioTeam had a chance to speak with Tom recently to appreciate how J&J is leveraging cloud compute and storage resources to maximize innovation and growth while controlling costs.

Nov 30, 2021, 01:00 AM by User Not Found

Bio-IT World | Illumina powers the Canadian COVID-19 Genomics Network, organ-on-a-chip explores infectious disease, and cell analysis acquisitions. Plus new products from PerkinElmer, Bio-Rad, Roswell Biotechnologies, Genialis, and more.

Nov 24, 2021, 13:46 PM by

Nov 24, 2021, 13:46 PM by

The next phase of market growth is likely to be driven by rising demand for personalized medicine, technological advancements, favourable funding environment, growing incidence of cancer & genetic disorders.

Nov 24, 2021, 13:46 PM by

Innovation experts Linda Kasim, Imran Haq and Anca Ciobanu share predictions for innovation in life sciences for the year ahead

Nov 24, 2021, 13:46 PM by

Nov 24, 2021, 13:46 PM by